Inhibition of PRMT5 moderately suppresses prostate cancer growth in vivo but enhances its response to immunotherapy

Qinju He, Yuanzhen Zhang, Wenchao Li, Saisai Chen, Jiangling Xiong, Ruizhe Zhao, Kai Yuan, Qiang Hu, Song Liu, Guozhen Gao, Mark T. Bedford, Dean G. Tang, Bin Xu, Cheng Zou, Dingxiao Zhang, Dingxiao Zhang